Showing results (411-420 of 538) with videos related to

Sort By:
Pageof 54
Open Forum Infectious Diseases|August 6, 2020
Invasive Aspergillosis as an Under-recognized Superinfection in COVID-19George R Thompson Iii, Oliver A Cornely, Peter G Pappas, et al.
Virulence|June 9, 2016
Repurposing auranofin as an antifungal: In vitro activity against a variety of medically important fungiNathan P Wiederhold, Thomas F Patterson, Anand Srinivasan, et al.
The Journal of Antimicrobial Chemotherapy|December 2, 2017
Impact of unresolved neutropenia in patients with neutropenia and invasive aspergillosis: a post hoc analysis of the SECURE trialDimitrios P Kontoyiannis, Dominik Selleslag, Kathleen Mullane, et al.
Antimicrobial Agents and Chemotherapy|April 1, 2024
Ibrexafungerp is efficacious in a neutropenic murine model of pulmonary mucormycosis as monotherapy and combined with liposomal amphotericin BTeclegiorgis Gebremariam, Sondus Alkhazraji, Yiyou Gu, et al.
The Journal of Infectious Diseases|October 1, 1996
Detection and significance of fluconazole resistance in oropharyngeal candidiasis in human immunodeficiency virus-infected patientsS G Revankar, W R Kirkpatrick, R K McAtee, et al.
Journal of Clinical Microbiology|December 8, 2004
Comparison of antifungal susceptibilities to fluconazole and voriconazole of oral Candida glabrata isolates from head and neck radiation patientsA K Burn, A W Fothergill, W R Kirkpatrick, et al.
Journal of the American Veterinary Medical Association|September 1, 1989
Testicular feminization in a catV N Meyers-Wallen, J D Wilson, J E Griffin, et al.
Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics|January 13, 2004
Candida glabrata is an emerging cause of oropharyngeal candidiasis in patients receiving radiation for head and neck cancerSpencer W Redding, Marta C Dahiya, William R Kirkpatrick, et al.
Pageof 54